Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 3 | Unknown | — |
After couple of doses of Vivotif, the patient had the dentist prescribing Amoxicillin. The patient took three doses of Vivotif in total.; Case reference number US-BN-2025-001089 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-1444) on 18-Jun-2025 and concerns a female patient of unknown age (date of birth: XX-Jun-1951). The patient's medical history and concomitant medication were not provided. On an unspecified date, the patient took first dose of Vivotif (batch number: unknown) at an unknown dose, or route of administration for an unknown indication. On an unspecified date, unknown amount of time after the first dose of Vivotif, the patient took second dose of Vivotif (batch number: unknown) at an unknown dose, or route of administration. On an unspecified date, unknown amount of time after the second dose of Vivotif, the patient took third dose of Vivotif (batch number: unknown) at an unknown dose, or route of administration. On an unspecified date, as reported after couple of doses, the patient had the dentist prescribing amoxicillin (explicitly coded as 'contraindicated product administered'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. No further information was provided.; Reporter's Comments: This case concerns a female patient of unknown age, who received three doses Vivotif vaccine on an unspecified dates and unknown time intervals between the doses. As reported, the patient had amoxicillin as prescribed by her dentist which is considered as 'contraindicated product administered'. Contraindicated product administered is considered as listed per company conventions. The patient's medical history and concomitant medication details were not provided. At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Contraindicated product administered is assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: This case concerns a female patient of unknown age, who received three doses Vivotif vaccine on an unspecified dates and unknown time intervals between the doses. As reported, the patient had amoxicillin as prescribed by her dentist which is considered as 'contraindicated product administered'. Contraindicated product administered is considered as listed per company conventions. The patient's medical history and concomitant medication details were not provided. At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Contraindicated product administered is assessed as not related to suspect product but to human factor. The case is non-serious.
Comments: None.
AMOXICILLIN